Our Medical Advisors

The Neuro Foundation works closely with a group of health professionals who represent the key specialties involved in Neurofibromatosis care. The main roles of the advisors are to:

  • Provide medical knowledge and training for our own Specialist Advisors and office staff.
  • To help develop and update our factsheets.
  • To assess requests from researchers who want to recruit people from our membership to their studies.
  • To provide a medical and scientific perspective on The Neuro Foundation’s development.

Our Medical Advisors:

Gareth Evans

Gareth Evans

Professor Evans has established a national and international reputation in clinical and research aspects of cancer genetics, particularly in neurofibromatosis and breast cancer. He has developed a clinical service for cancer genetics in the North West Region of England, which is nationally regarded. He is an important opinion leader nationally through membership of committees and was chairman of the NICE Familial Breast Cancer Guideline Development Group (2002-2010) and is now clinical lead (2011-). He lectures throughout the UK and internationally on hereditary breast cancer and cancer syndromes. He has given plenary lectures at many international meetings including the International Congress of Human Genetics and two invited lecture tours across Australia. He has developed a national training program for clinicians, nurses and genetic counsellors in breast cancer genetics and established a system for risk assessment and counselling for breast cancer in Calman breast units implemented through a training course (1998-2011). He has published 529 peer reviewed research publications; 198 as first or senior author. He has published over 80 reviews and chapters and has had a book published by Oxford University Press on familial cancer. He has an ISI web of knowledge H-index of 72 having only published his first article in 1990. In the last 5 years he has raised over £10 million in grants for multicentre and local studies - approximately £5 million to Manchester. He is Chief Investigator on a 1.59 million NIHR program grant (2009-2014) on breast cancer risk prediction and also has an NIHR RfPB grant as CI (2011). He has led a successful bid for a nationally funded NF2 service (7.5 million p.a.) that started in 2010 and is involved in the national complex NF1 service.
Professor Rosalie Ferner

Professor Rosalie Ferner

Consultant and Professor of Neurology at Guys and St Thomas's Hospital and Chair of the Medical Advisory Board of The Neuro Foundation. Professor Ferner has been national lead for the nationally commissioned NF1 service since 2009, and lead for the London NF2 service since 2010. The aim of the national neurofibromatosis services is to give expert, multi-disciplinary, holistic care to people with complex, multi-system disease. Her specialist clinical work is in tumour suppressor conditions – NF 1 and 2, Schwannomatosis and von Hippel Lindau disease.
Dr Sue Huson

Dr Sue Huson

Consultant Clinical Geneticist, based at St Mary’s Hospital in Manchester. She now specialises completely in the diagnosis and management of the different forms of neurofibromatosis. She is clinical lead for the North of England nationally commissioned Complex NF1 service and works alongside Professor Gareth Evans who leads the Northern NF2 service.
Professor Meena Upadhyaya

Professor Meena Upadhyaya

Professor of Medical Genetics at Cardiff University. She obtained her PhD from Cardiff University and gained Fellowship of the Royal College of Pathology (FRCPath), London. Prof Upadhyaya has made substantial contributions to the understanding of molecular basis of a number of genetic conditions including NF1, Fascioscapulohumeral Muscular Dystrophy (FSHD), Legius syndrome, Charcot Marie Tooth disease, Sotos syndrome, Hunters syndrome, plus several others.She has researched NF1 for the past 25 years and has contributed to the mapping and cloning of the NF1 gene. She has been on the Steering Committee of NF1 mutation analysis. Meena Upadhyaya's research has focused on Cancer Genetics of NF1, which is beginning to generate potential therapeutic targets. She is on many research and management committees and has chaired both national and international meetings, as well as supervising numerous post-graduate students for their MD or PhD degrees. She has also published over 160 papers in reputable journals, written 25 book chapters and edited three books.
Jeremy Fairbank

Jeremy Fairbank

Consultant Orthopaedic Surgeon, Oxford
Oliver Hanemann

Oliver Hanemann

Consultant and Professor of Neurology, Plymouth
Ian Simmons

Ian Simmons

Consultant Paediatric Ophthalmologist, Leeds
Nick Thomas

Nick Thomas

Consultant Neurosurgeon, King’s College London
Dr Alastair Santhouse FRCP, FRCPsych

Dr Alastair Santhouse FRCP, FRCPsych

Dr Alastair Santhouse is a Consultant Psychiatrist in Psychological Medicine, at The South London & Maudsley. His special interest is in general hospital psychiatry, and he has worked in the Guy’s Hospital NF service for 10 years, in the multidisciplinary clinic.
Dr Zaby Bassi

Dr Zaby Bassi

Shruti is a Child Psychiatrist and Neuroscientist I did my general medical training at Grant Medical College, Mumbai India beofre training in general psychiatry at Oxford & Leeds. I moved to Manchester in 2008 to specialise in Child & Adolescent Psychiatry. I was awarded a research training fellowship by NIHR Bioedical Research centre in 2011-12 to study the behavioural phenotype of Neurofibromatosis type 1 (NF1). My PhD thesis described for the first time, a high prevalence of Autism Spectrum Disorders (ASD) in NF1. This work formed the basis for my research programme in NF1 autism. Clinically I run the regional Social Development Clinic and a specialist NF1 liaison service at the Royal Manchester Children's Hospital.
Shruti Garg

Shruti Garg

Shruti Garg is a Consultant in Child & Adolescent Psychiatry and a Clinical Research Fellow at the Institute of Brain, Behaviour and Mental Health, University of Manchester, UK. Her research and clinical interests include neuropsychiatry and neurobiology of developmental disorders. Over the past 4 years she has studied the psychiatric morbidity in Neurofibromatosis Type 1 particularly looking at the prevalence of autism spectrum disorder. Along with working with the Social Development clinic she leads a specialist NF1 psychiatry clinic in Manchester.
Thomas Carroll

Thomas Carroll

Thomas is a Consultant Neurosurgeon and Deputy Clinical Director of Neuroscience at Sheffield Teaching Hospitals NHS Foundation Trust, as well as a senate member of an NHS England Specialist Commissioning Clinical Reference Group and an 'expert' member of a National Research Ethics Service regional ethics committee.
Andrew Hayes

Andrew Hayes

Mr Hayes has both a private and an NHS practice at The Royal Marsden. He is a Consultant General Surgeon and Surgical Oncologist on the Sarcoma Unit and the Skin Unit. He qualified at Oxford University and St Bartholomew's Hospital, London, and undertook his surgical training in London and a PhD in Washington DC. Mr Hayes has a specialist practice in soft-tissue sarcoma and advanced melanoma, and operates on over 150 cases of sarcoma and another 150 of cases of advanced malignant melanoma a year. Mr Hayes leads the isolated limb perfusion programme which provides a national service for regional chemotherapy for patients with advanced limb malignancy. Mr Hayes is Head of The Royal Marsden's Skin Unit, Chair of the South West London Sarcoma Tumour Working Group and Clinical Lead for the Rare Cancers Clinical Business Unit at The Royal Marsden. Mr Hayes was awarded a Hunterian Professorship in 2002 for his research into angiogenesis as a therapeutic approach for cancer. In 2014 he was appointed as Honorary Associate Faculty at the Institute of Cancer Research and he is Team Leader of the Sarcoma and Melanoma Surgery Research Group at the ICR. He has a laboratory research program investigating new therapies for extremity malignancies using isolated limb perfusion and he has published widely in the fields of sarcoma and melanoma.
Andrew King

Andrew King

Connect your social media account to Thunderclap to help us to shout about NF on World NF Day 2018